Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC67H86N6O11 |
InChIKeyIDYPTMWWAIUKKF-KLXQAYBZSA-N |
CAS Registry2095245-13-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | Japan | - | |
| Neoplasms | Preclinical | Japan | - |





